Clinical trial
BioHealx® Anal Fistula Device Post Market Surveillance Study
NCT07021742 is registered in ClinicalTrials.gov with Signum Surgical USA Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BioHealx® Anal Fistula Device Post Market Surveillance Study
- Lead sponsor
- Signum Surgical USA Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 14, 2025
- Completion date
- December 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
fistula-in-ano